FDA Ortho Panel Gives Advice On Spinal Device Trial Design
This article was originally published in The Gray Sheet
Executive Summary
FDA should be flexible in its protocol guidelines for clinical trials of implanted devices for treating mild to moderate back pain, members of FDA's Orthopaedic & Rehabilitation Devices Panel agreed Sept. 9
You may also be interested in...
St. Francis And Cardica Try For New Technology Add-On Payments In FY ’07
St. Francis Medical Technologies believes its X-Stop interspinous decompression device for lumbar spinal stenosis should qualify for a new technology add-on payment in FY '07 because it is a less invasive alternative to spinal fusion and laminectomy
St. Francis And Cardica Try For New Technology Add-On Payments In FY ’07
St. Francis Medical Technologies believes its X-Stop interspinous decompression device for lumbar spinal stenosis should qualify for a new technology add-on payment in FY '07 because it is a less invasive alternative to spinal fusion and laminectomy
St. Francis’ X-Stop Gets FDA Green Light To Treat Lumbar Spinal Stenosis
St. Francis Medical Technologies will begin marketing the X-Stop non-fusion device for lumbar spinal stenosis in January to experienced surgeons in order to build the product's reputation